Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Biochimie|January 11, 2021
LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3Uttam Sharma, Tushar Singh Barwal, Akanksha Khandelwal, et al.Frontiers in Immunology|May 27, 2024
The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic reviewBibhu Prasad Satapathy, Pooja Sheoran, Rohit Yadav, et al.Frontiers in Pharmacology|December 24, 2019
Molecular Mechanisms of Action of Genistein in Cancer: Recent AdvancesHardeep Singh Tuli, Muobarak Jaber Tuorkey, Falak Thakral, et al.Diseases (Basel, Switzerland)|March 26, 2025
Clinical Significance of LINC00261 in the Pathogenesis of Pancreatic, Colorectal, Hepatocellular, and Gallbladder CancerSanjana Bana, Sia Daffara, Aastha Dagar, et al.Critical Reviews in Oncology/Hematology|July 2, 2021
NOTCH signaling: Journey of an evolutionarily conserved pathway in driving tumor progression and its modulation as a therapeutic targetVaishali Aggarwal, Hardeep Singh Tuli, Mehmet Varol, et al.Molecular Biology Reports|April 27, 2022
STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulationHardeep Singh Tuli, Katrin Sak, Ashif Iqubal, et al.Genes|March 28, 2025
MYOSLID: A Critical Modulator of Cancer HallmarksKanupriya Medhi, Sagarika Mukherjee, Aastha Dagar, et al.The Journal of Biological Chemistry|February 3, 2011
Non-B DNA-forming sequences and WRN deficiency independently increase the frequency of base substitution in human cellsAlbino Bacolla, Guliang Wang, Aklank Jain, et al.Biomarkers in Medicine|December 14, 2023
Emerging role of miR-320a in lung cancer: a comprehensive reviewAdrija Mohanta, Rajiv R Kumar, Rahul K Singh, et al.Biomarkers in Medicine|February 23, 2022
Clinical potential of long non-coding RNA LINC01133 as a promising biomarker and therapeutic target in cancersUttam Sharma, Tushar Singh Barwal, Masang Murmu, et al.Pageof 8